Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 04.06.2025       https://research-hub.de/companies/Koenig & Bauer AG

Koenig & Bauer (SKB) has successfully completed the proof-of-concept phase for its dry-coating system in partnership with Volkswagen’s PowerCo, marking a key milestone in its diversification into battery technology. The validated system now moves into pilot-scale testing, with industrial rollout targeted for 2026. This breakthrough confirms SKB’s ability to transfer core engineering expertise to highgrowth sectors like e-mobility. While mwb research’s analysts do not yet factor potential revenues into their model, the commercial upside could reach several hundred million euros. Given PowerCo’s EUR 20bn investment plan and SKB’s exclusivity window, the analysts see substantial long-term optionality. With the stock trading at just 6x 2026E P/E and EBITDA set to grow tenfold by 2027, mwb research reiterates the BUY rating and maintains the EUR 21.00 PT. The full update can be downloaded under https://www.research-hub.de/companies/research/Koenig%20&%20Bauer%20AG
Wed, 04.06.2025       https://research-hub.de/companies/Leifheit AG

Leifheit has announced its entry into the EUR 200m European dusting market—an important strategic move to reinforce its position in sustainable mechanical cleaning. The launch of SUPERDUSTER supports the company’s innovation agenda and strengthens its core Household portfolio, aligning with growing consumer demand for reusable, eco-friendly products. Early market feedback has been positive, suggesting solid commercial potential. This development should enhance brand differentiation, support cross-selling, and contribute to margin improvement via favorable product mix and scaling benefits. While near-term consumer demand remains soft, Leifheit’s long-term growth strategy continues to progress. mwb research’s analysts make no changes to their estimates or valuation but view the new product line as a supportive factor for delivering on guidance. The analysts maintain their BUY rating and EUR 30.00 price target, seeing this as a value-accretive step in the company’s strategic execution. The full update can be downloaded under: https://research-hub.de/companies/leifheit-ag
Wed, 04.06.2025       https://research-hub.de/companies/KWS SAAT SE & Co KGaA

At mwb research’s “New Food Investor Conference,” Peter Vogt, Head of Investor Relations at KWS, shared insights into the company’s strategy and future outlook. He emphasized KWS’s strengths and answered questions about its position in the seed breeding market, particularly highlighting its growing vegetables segment. KWS is a leading European seed breeder with a strong global presence and a focus on non-GMO crops such as sugarbeet, corn, cereals, and vegetables. The company’s profitable growth is driven by innovation and a strong R&D platform. With rising global demand for premium seeds, KWS is well positioned for long-term success. The vegetables segment, though small, shows strong potential, with new varieties expected soon. KWS’s strategic investments and innovation pipeline support a compelling long-term growth outlook. mwb research’s analysts maintain their BUY rating and PT of EUR 83.00 based on conservative estimates. You can find the recording here: https://research-hub.de/events/video/2025-06-03-09-30/KWS-GR. The full update can be downloaded under https://research-hub.de/companies/kws-saat-se-co-kgaa
Wed, 04.06.2025       https://research-hub.de/companies/Geratherm Medical AG

Geratherm’s FY24 results showed a 33% revenue decline to EUR 14.0m, primarily due to sharp drops in Healthcare Diagnostics and Incubator Systems, as well as the sale of the Cardio/Stroke (apoplex) business. However, strong 30% growth in the Respiratory division, which now accounts for over half of total revenues, partially offset this decline. EBIT fell 42% but the margin remained in double digits, helped by cost reductions and gains from the apoplex sale. While Diagnostics remains challenged by market saturation and price pressure, Respiratory and Incubator Systems are positioned for growth in FY25, following new certifications and product launches. With a strengthened balance sheet and positive segment momentum, mwb research’s analysts maintain a BUY rating, albeit with a revised price target of EUR 6.00 (old: EUR 7.00). The full update can be downloaded under https://www.research-hub.de/companies/Geratherm%20Medical%20AG
Tue, 03.06.2025       Datagroup SE

Company Name: Datagroup SE ISIN: DE000A0JC8S7   Reason for the research: Update Recommendation: Hold from: 03.06.2025 Target price: 58 Last rating change: Analyst: Sebastian Droste Strong order uptick in Q2 On 27 May 2025, Datagroup released its Q2 financial results and confirmed its guidance for FY 2024/2025. Revenue growth was  [ … ]
Tue, 03.06.2025       Somec S.p.A.

Company Name: Somec S.p.A. ISIN: IT0005329815   Reason for the research: Research study (Initial Coverage) Recommendation: BUY Target price: 22.50 EUR Last rating change: Analyst: Marcel Goldmann, Cosmin Filker The order backlog at the end of the past financial year totalled € 744.0 million (of which around 66.0% was attrib [ … ]
Tue, 03.06.2025       Verve Group SE

Company Name: Verve Group SE ISIN: SE0018538068   Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 03.06.2025 Target price: €6 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE0018538068) ver [ … ]
Tue, 03.06.2025       https://research-hub.de/companies/Swiss Estates AG

Swiss Estates AG reported disappointing FY24 results, with a net loss of CHF 7.0m (mwb est.: CHF 4.5m profit), mainly due to one-off impacts from the sale of a Zurich asset and CHF 5.8m in tax charges. EBITDA dropped 81.6% to CHF 0.7m, reflecting high transaction costs and legal fees. Despite stable rental income and a sound strategy shift toward residential assets, recurring earnings remain weak. NAV per share fell 17.1% to CHF 11.74 but at the same time, leverage remains manageable with an LTV of 62.5%. Due to reduced earnings visibility, mwb research’s price target is lowered from CHF 7.50 to CHF 5.00, but mwb research’s analysts maintain a BUY rating based on long-term upside potential. The full update can be downloaded under https://www.research-hub.de/companies/Swiss%20Estates%20AG
Tue, 03.06.2025       https://research-hub.de/companies/Viscom SE

Viscom is emerging from a cyclical downturn in its core automotive segment, supported by restructuring efforts and a leaner cost base that restored profitability in Q1’25. While the broader auto market remains uneven across regions, early signs of stabilizing inventories, plateauing input costs, and rising EV demand, particularly in Asia, suggest that the market is likely in the late stages of a cyclical trough. Management anticipates a stable performance for 2025, with a return to growth expected in 2026, in line with broader OEM expectations. Although the recovery is likely to be gradual and bumpy due to ongoing geopolitical and trade uncertainties, mwb research’s analysts believe Viscom is well positioned to benefit from the next wave of automotive capex cycle, supported by its technological edge and exposure to industry megatrends. In parallel, the company is actively diversifying its revenue base, with early aerospace revenues, progress in defense, and commercial rollout efforts in the back-end semiconductor segment. mwb research’s analysts reiterate to BUY and price target of EUR 4.80. The full update can be downloaded under https://research-hub.de/companies/viscom-se
Tue, 03.06.2025       CR Energy AG

Company Name: CR Energy AG ISIN: DE000A2GS625   Reason for the research: Update Recommendation: Under Review from: 03.06.2025 Target price: n.a. Target price on sight of: 12 months Last rating change: Analyst: Philipp Sennewald CRE set to file for insolvency; Rating suspended In an ad hoc announcement released Friday afternoon,  [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 12.07.2025, Calendar Week 28, 193rd day of the year, 172 days remaining until EoY.